Your browser doesn't support javascript.
loading
CRUSE - What the first 100 days have taught us.
Neisinger, Sophia; Pinto, Bernardo Sousa; Ramanauskaite, Aiste; Bousquet, Jean; Weller, Karsten; Metz, Martin; Magerl, Markus; Kocatürk, Emek; Ojeda, Ivan Cherrez; Gimenez-Arnau, Ana M; Maurer, Marcus.
Afiliação
  • Neisinger S; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Email: sophia.neisinger@charite.de.
  • Pinto BS; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Ramanauskaite A; MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Bousquet J; CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
  • Weller K; RISE-Health Research Network, University of Porto, Porto, Portugal.
  • Metz M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Email: sophia.neisinger@charite.de.
  • Magerl M; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Kocatürk E; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Email: sophia.neisinger@charite.de.
  • Ojeda IC; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Gimenez-Arnau AM; MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Maurer M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Email: sophia.neisinger@charite.de.
Qatar Med J ; 2023(2): 14, 2023.
Article em En | MEDLINE | ID: mdl-38025340

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Qatar Med J Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Qatar Med J Ano de publicação: 2023 Tipo de documento: Article